Insider Transactions in Q3 2022 at Fulgent Genetics, Inc. (FLGT)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 06
2022
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
662
-0.44%
|
$27,142
$41.39 P/Share
|
|
Aug 30
2022
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
675
-0.22%
|
$29,700
$44.18 P/Share
|
|
Aug 17
2022
|
Hanlin Gao Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
370
-0.04%
|
$17,760
$48.89 P/Share
|
|
Aug 17
2022
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
1,945
-1.28%
|
$93,360
$48.89 P/Share
|
|
Aug 17
2022
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
1,414
-0.45%
|
$67,872
$48.89 P/Share
|
|
Aug 03
2022
|
Paul Kim CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,048
-0.68%
|
$64,976
$62.93 P/Share
|
|
Aug 03
2022
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,343
-1.99%
|
$393,266
$62.93 P/Share
|
|
Aug 01
2022
|
Michael Nohaile |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+50.0%
|
-
|
|
Aug 01
2022
|
Ming Hsieh Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+50.0%
|
-
|
|
Aug 01
2022
|
Leonard E Post Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+50.0%
|
-
|
|
Aug 01
2022
|
Linda Marsh |
BUY
Grant, award, or other acquisition
|
Direct |
1,600
+22.22%
|
-
|
|
Aug 01
2022
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
872
-0.27%
|
$51,448
$59.54 P/Share
|
|
Aug 01
2022
|
John C Bolger Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,600
+23.88%
|
-
|
|
Jul 30
2022
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
87
-0.01%
|
$5,133
$59.75 P/Share
|